It may not have been pretty, but Regulus Therapeutics ($RGLS) raised close to $81 million from its recent IPO and some related transactions. And the company did it with a big assist from some major league partners in the biopharma industry. Report
| Wednesday, January 28, 2015 | 11am ET / 8am PT | Sponsored by: Catalent
BASF SE expert Andreas Gryczke will present fundamental understanding of Role of Polymers using hot melt extrusion technology and Catalent's expert Dr. Sampada B Upadhye will present unique approach to formulation development and strategy for scale-up. Learn How BASF & Catalent can Expedite and Resolve your Challenges with development and manufacturing.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!